Veriheal

AUGUST 24, 2022

Colorado could legalize psychedelics. These include legalizing the possession, cultivation, use, and sharing of psychedelic components such as ibogaine , mescaline , DMT, psilocybin , and psilocin for adults over the age of 21. Research and Testimonials Point to Psychedelics’ Therapeutic Benefits. city to do so.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The FDA refers to this program as the expanded access program on their website. We would love to hear your thoughts in the comments below!

Therapy 55

Therapy DEA Patients Clinical Trials 55

The Blunt Truth

MAY 15, 2020

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. We’ve got an update on the latest Montana legalization developments. Maine made changes to their marijuana program. Groups opposing marijuana legalization said the measure “makes no sense.”

Banking 106

Banking Research and Development Programs Advocacy 106

Canna Law Blog

MARCH 7, 2023

Kate Robertson at MJBizDaily reported on March 1, on a first of its kind development in the space. EB-5 program. The INA contains an immigrant investor program at 8 USC § 1153(b)(5) that allows foreign nationals to apply for permanent residence by making a minimum investment in a new commercial enterprise in the U.S.

DEA 70

DEA Research and Development Programs Cannabis 70

Veriheal

SEPTEMBER 9, 2021

Rather than a ballot initiative , Connecticut, New Mexico, New York, and Virginia legalized the plant for adult-use purposes via a legislative process. They follow in the footsteps of Vermont, which became the first legislative-driven legal cannabis state back in 2018. Legal Cannabis Business Framework .

Legalization 109

Legalization Recreational Business Retail 109

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

JULY 23, 2021

Today, adult use of cannabis, which is classified as a Schedule 1 controlled substance under the Controlled Substances Act (CSA), is legal in 18 states, and the medical use of cannabis is legal in 37 states, though cannabis use remains illegal under federal law. Research, Training and Prevention.

Research and Development 105

Research and Development DEA Programs State Laws 105

Nature's Way Medicine

FEBRUARY 12, 2021

In this week’s news and updates, we have updates about how Ohio’s medical marijuana market is doing, political lobyists in the cannabis industry, and the Senate’s push for legalization. Senate Majority Leader Chuck Schumer Spearheads Effort to Legalize Cannabis. Cannabidiol and Marihuana Research Expansion Act.

Research and Development 97

Research and Development Patients CBD DEA 97

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

The Cannigma

MAY 15, 2023

Because ketamine promotes neuroplasticity, or in other words helps “rewire” the brain,” research shows that it can help stop the repetitive negative thoughts and behaviors that are at the core of many mental health conditions.

Therapy 78

Therapy Access Blood Pressure Treatment 78

SMPL

FEBRUARY 11, 2020

President Trump proposed ending an existing policy that protects state medical marijuana programs from Justice Department interference as part of his fiscal year 2021 budget plan released on Monday. from using local tax dollars to legalize marijuana sales.

Research and Development 40

Research and Development Legalization Marijuana Programs 40

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Now, we are closer than ever to legalizing MDMA-assisted therapy for posttraumatic stress disorder (PTSD), though there is still a long road ahead. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Canna Law Blog

OCTOBER 27, 2020

Legal psilocybin in Oregon? As a refresher, Measure 109 would legalize the manufacture, delivery and administration of psilocybin, but only at supervised, licensed facilities. The Oregon program will not square with federal laws. We like the sound of that. But do we unconditionally and unapologetically love the ballot measure?

DEA 80

DEA Decriminalization Research and Development Programs 80

United Patients Group

APRIL 3, 2023

A recommendation from a physician is simply permission (‘recommendation’) for the patient to use cannabis, which can be obtained in any state where medical marijuana is legal. Although both are legal under state law, there are currently 29 states with legislation allowing for medical cannabis and the District of Columbia.

DEA 52

DEA Patients Conditions Cannabis 52

CannaMD

AUGUST 8, 2020

Researchers believe cannabis contains over 100 unique chemical compounds! But CBD’s real calling card is that it’s popularly isolated from marijuana’s sibling plant, hemp , and can be legally sold (in most states) under much more relaxed regulations. One big myth is that the Farm Bill makes hemp-derived CBD legal.

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

AUGUST 18, 2022

One year after the United States Department of Agriculture (USDA) issued its final rules on hemp, various states enacted their own regulatory programs. Although ACS Laboratory foresees federal legalization for cannabis in the future, it may be years before national laboratory standards are created. BOCA RATON, Fla., Source: [link].

Compliance 52

Compliance Compliance Hemp Research and Development 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Program between St. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JULY 1, 2021

On June 30th, the Petrie-Flom Center announced the launch of a three-year research initiative , the Project on Psychedelics Law and Regulation (POPLAR) , which is supported by a generous grant from the Saisei Foundation. POPLAR will publish original law and policy research. What barriers exist to conducting psychedelics research?

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

APRIL 21, 2022

MAPS and MAPS PBC have developed the first validated commercial synthetic process for producing multi-kilogram batches of MDMA under current Good Manufacturing Practices. The full statement. Nair, Ph.D., lead author and MAPS PBC Head of Chemistry, Manufacturing, and Controls. Berra Yazar-Klosinski, Ph.D.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

MedicalJane

JUNE 29, 2018

On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. The Next Move Is On The DEA. FDA Grants Approval of Epidiolex.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

JULY 9, 2021

This article provides an overview of the current state of legality of common psychedelic substances, and some of the potential therapeutic uses to which psychedelics may be applied. Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances.

Law 105

Law Therapy Clinical Trials Research and Development 105

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

Modern societies continue to do so at high rates, both in areas where it has been legalized and those where it remains outlawed. More States Favor Cannabis Legalization. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.

Recreational 52

Recreational Data Cannabis DEA 52

Cannabis Law Report

JULY 28, 2022

An Examination of the USDA Hemp Production Program. Testimonies During The House Agriculture Subcommittee On Biotechnology, Horticulture, And Research Addressed FDA Inaction on CBD and Intoxicating Hemp Derivatives. Washington D.C. Today, U.S. That reluctance, in turn, has dampened industry demand for harvested hemp material.”. “In

Agriculture 52

Agriculture Hemp CBD Research and Development 52

SMPL

AUGUST 14, 2019

Though ABA specified that it was not taking a position on marijuana legalization generally, it recognized that conflicting federal and state cannabis policies are untenable and have created complications for cannabis businesses operating in compliance with state law.

Policy 40

Policy Research and Development Marijuana DEA 40

SpeedWeed

FEBRUARY 24, 2021

Noncompliant hemp used to require its disposal or remediation be conducted by a government official from an agency like the DEA. Hemp must be tested at DEA-registered laboratories, as previous rules state. 3% an extreme limit for hemp genetics and cultivators, positing that the rule will limit innovation and plant research.

Hemp 52

Hemp DEA Research and Development Compliance 52

Cannabis Law Report

APRIL 13, 2022

North American Industry Leader in Psychedelic Therapy and Research. Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Watch Video: The Press Release. NEWS PROVIDED BY. Numinus Wellness Inc. .

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

NOVEMBER 2, 2021

This is a well researched and detailed report and is, we suggest required reading. Customers looking for a “weed light” experience could be getting something decidedly heavy , with delta-9 THC levels well beyond the legal limit and very little in the way of testing for impurities. The Legality of Delta-8 THC. Executive Summary.

THC 96

THC CBD Legalization Vaping 96

Project CBD

AUGUST 23, 2023

Collectively, this language has fostered a regulatory gap that companies are taking advantage of to sell highly intoxicating products, colloquially and misleadingly referred to in the national unregulated hemp marketplace as “legal cannabis.” The amount of hemp under cultivation in the U.S. has shrunk by 48 percent since 2021.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Cannabis Law Report

JULY 28, 2021

To a large extent legalization of adult-use cannabis, including New York’s passage of the Marijuana Regulation and Taxation Act of 2021 (MRTA), has eclipsed other developments in the cannabis sector over the past year. 5940), which allows hemp to be cultivated for research (as opposed to commercial) purposes. 27 July 2021.

THC 105

THC Hemp CBD Cannabinoids 105

Cannabis Law Report

JUNE 4, 2021

Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

The Cannigma

SEPTEMBER 12, 2021

THC is the most prevalent, famous and researched cannabinoid by far. The reason these two cannabinoids have become so popular in the United States is because of a legal contradiction created by the 2018 Farm Bill, which declared products derived from hemp to be legal. Is THC legal in the US? Who discovered THC?

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

JULY 30, 2019

Considering our current armed service use restrictions and the lack of legal tax and employment considerations for marijuana use, like the nation, Florida is not quite “ there ” yet. . Most reliable medical cannabis research filters into the U.S. “People do not know what’s going on. Federal Register. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

AUGUST 16, 2019

: “ A Florida court of appeals decision last month ruled that the state’s regulatory framework for its medical cannabis program mandating vertical integration was unconstitutional. ” What specific growth did the current Florida program experience? What does it mean for Florida’s system, or for other states?

Marijuana 49

Marijuana Research and Development Seed-To-Sale Education 49

Cannabis Law Report

APRIL 14, 2022

Cannabis cultivation and processing are rapidly-growing industries, as hemp and both recreational and medical marijuana products are being legalized across the country. With this rapid growth and legalization, however, comes added regulatory scrutiny, including in the environmental and sustainability spaces. Larkin , Sheryl Sweeney.

Environment 52

Environment Agriculture Compliance Compliance 52

SpeedWeed

MARCH 5, 2021

Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Removing cannabis from the CSA, a/k/a descheduling, would not amend its legal definition in such a way that it would meet either requirement. Rescheduling cannabis will not necessarily facilitate clinical research. By Paul Armentano.

Business 52

Business Policy Clinical Trials Research and Development 52

Otherside Farms

AUGUST 4, 2020

Concrete extraction technicians, researchers, marijuana cultivators, marketers, marijuana processors, cannabis branding, and developers will all have a place in the industry. There are a number of ways that your skills can be used to develop a business. Research Your Competitors. Fund your Business.

Business 52

Business Banking Dispensary Research and Development 52